Auth bypass in Dexma Dexgate
CVE-2023-41089
The affected product is vulnerable to an improper authentication vulnerability, which may allow an attacker to impersonate a legitimate user as long as the device keeps the session active, since the attack takes advantage of the cookie header to generate "legitimate" requests.
Vulnerability class: Broken Authentication
Published · last modified .
CVSS v3 metric
CVSS v3 base score 8.0 (High). Vector: CVSS:3.1/AV:A/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H.
EPSS exploit prediction
EPSS: 0.005 (41.9th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 42nd percentile — 41.9% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.005 · newest: 0.005 · change: 0.000
Affected products
- Dexma Dexgate — versions 20130114, version 20130114
Weakness classification (CWE)
References
- www.cisa.gov/news-events/ics-advisories/icsa-23-271-02 (US Government Resource, Third Party Advisory)
Frequently asked questions
- What is CVE-2023-41089?
- CVE-2023-41089 is a high-severity vulnerability in Dexma Dexgate, classified under Improper Authentication. CVSS score: 8.0/10. Published 2023-10-19.
- How severe is CVE-2023-41089?
- High severity. CVSS v3 base score is 8.0 out of 10.